FDA Recommends Testing All Blood Donations for Zika
The FDA is now recommending universal testing of blood donations in the U.S. as a further strategy against what they’re calling an emerging Zika virus outbreak.
The FDA issued a similar recommendation in February, but that was only for areas with an active Zika virus transmission. Part of that recommendation to halt blood collection in those areas, especially if screening wasn’t an option.
The group recommended obtaining blood donations from other parts of the U.S. without active virus transmission.
The FDA is now updating those guidelines to test more blood donations for the virus.
Testing of donated blood is already underway in Florida and Puerto Rico and the FDA say’s it’s helped in identifying donations infected with the virus. The agency says expanded testing will continue to reduce the risk of transmission of the virus through blood transfusions.